Bob-
There have been a lot of studies trying to determine whether adding an anti-androgen to a GnRH agonist conferred any benefit. A large meta-analysis showed that the increased benefit was only 2-3%, but due to the uncertainty in the meta-analysis, it may be as low as 0% or as high as 5%. Many doctors don't think the added side effects are worth it for so small a potential benefit.
www.thelancet.com/journals/lancet/article/PIIS0140-6736(00)02163-2/fulltextThere was a small randomized clinical trial about
whether dutasteride was beneficial along with ADT (Bicalutamide+GnRH agonist). It wasn't. In fact, the men using it progressed faster, although the difference was not statistically significant.They achieved the same PSA nadir with it and without it:
/www.ncbi.nlm.nih.gov/pmc/articles/PMC4250242/Certainly, if monotherapy failed to get your PSA low enough, that would be a good clue to explore other options.
Gynecomastia can be prevented with tamoxifen.